Followers | 130 |
Posts | 14996 |
Boards Moderated | 1 |
Alias Born | 06/04/2018 |
Wednesday, October 07, 2020 12:30:18 PM
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported preliminary, unaudited net product revenue for the third quarter ended Septe...
Find out more OCUL - Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter
Recent OCUL News
- Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024 • GlobeNewswire Inc. • 09/25/2024 11:30:00 AM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- Ocular Therapeutix™ to Present at September Retina Meetings • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Ocular Therapeutix™ to Present at Two Investor Conferences in September • GlobeNewswire Inc. • 09/04/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:08:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:17:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 08:18:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 09:10:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 08:36:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 09:32:38 PM
- Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/09/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/07/2024 08:15:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 11:23:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:13:30 AM
- Ocular Therapeutix™ Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/07/2024 11:10:00 AM
- Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study in Wet AMD • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:30:50 PM
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 07/31/2024 11:30:00 AM
- Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 10:41:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 10:40:11 PM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/18/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/17/2024 08:19:24 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM